HBK Investments’s Q32 Bio QTTB Stock Holding History

HBK Investments’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,556	Closed	-$524K	–	1187
2018 Q1	$524K	Buy	+1,556	New	+$523K	﹤0.01%	764

Other funds holding QTTB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

HBK Investments's QTTB Position: Q2 2018 in Review

HBK Investments sold out of Q32 Bio (QTTB) in Q2 2018, closing a stake of 1,556 shares — an estimated $524K sold.

HBK Investments first reported a position in QTTB in Q1 2018 and held it in 1 quarter. The position peaked at $524K in Q1 2018. 53 funds tracked by Wall St. Rank hold QTTB as of Q2 2018.

HBK Investments reported no remaining Q32 Bio position as of Q2 2018 after selling out during the quarter.
HBK Investments sold 1,556 Q32 Bio shares in Q2 2018, an estimated $524K.
HBK Investments first reported a position in Q32 Bio in Q1 2018 and held it in 1 quarter.
HBK Investments's Q32 Bio position peaked at $524K in Q1 2018.
53 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2018.

Based on HBK Investments's 13F filing for Q2 2018, filed 14 Aug 2018.